Frankfurt - Delayed Quote EUR
Kenvue Inc. (J4D.F)
At close: November 15 at 3:29 PM GMT+1
Research Analysis
Revenue vs. Earnings
Revenue 3.9B
Earnings 383M
Q4'23
Q1'24
Q2'24
Q3'24
0
1B
2B
3B
4B
Analyst Price Targets
No Analyst Price Targets available for this ticker
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 9 | 13 | 15 |
| Avg. Estimate | 3.79B | 4.01B | 15.58B | 16.08B |
| Low Estimate | 3.75B | 3.96B | 15.54B | 15.85B |
| High Estimate | 3.86B | 4.13B | 15.65B | 16.32B |
| Year Ago Sales | 3.67B | 3.89B | 15.44B | 15.58B |
| Sales Growth (year/est) | 3.41% | 2.92% | 0.90% | 3.21% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -- | -- | -- | -- |
| 7 Days Ago | -- | -- | -- | -- |
| 30 Days Ago | -- | -- | -- | -- |
| 60 Days Ago | -- | -- | -- | -- |
| 90 Days Ago | -- | -- | -- | -- |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | J4D.F | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.00% |
| Next Qtr. | -- | -- | -- | 12.00% |
| Current Year | -- | -- | -- | 2.10% |
| Next Year | -- | -- | -- | 12.20% |
Upgrades & Downgrades
| Maintains | B of A Securities: Buy to Buy | 10/22/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 10/11/2024 |
| Initiated | Jefferies: Buy | 9/24/2024 |
| Downgrade | RBC Capital: Outperform to Sector Perform | 9/24/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 9/23/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 8/7/2024 |
Related Tickers
CXX.SG Clorox Co
159.20
+1.27%
CXU.F Church & Dwight Co., Inc.
103.60
+0.88%
ELAA.DU The Estee Lauder Companies Inc
60.40
-1.63%
CPA.DE Colgate-Palmolive Company
87.97
+1.65%
ELAA.MU The Estee Lauder Companies Inc
60.60
-0.33%
CHD Church & Dwight Co., Inc.
109.02
+1.32%
UL Unilever PLC
57.40
0.00%
CL Colgate-Palmolive Company
93.56
+2.31%